Leadership Overview
SK pharmteco has 4 executives leading key functions including strategy, operations, organizational alignment, and small molecule manufacturing.
Focused on advancing global health through innovative drug development, SK pharmteco delivers comprehensive CDMO services for small molecules, biologics, and cell and gene therapies to clients worldwide.
Focused on advancing global health through innovative drug development, SK pharmteco delivers comprehensive CDMO services for small molecules, biologics, and cell and gene therapies to clients worldwide.
Leadership Roles at SK pharmteco
Joerg Ahlgrimm - Chief Executive Officer
Joerg Ahlgrimm, the Chief Executive Officer at SK pharmteco, directs the overarching corporate strategy and global vision for the organization. Overseeing the integration of small molecule, biologic, and cell and gene therapy capabilities, the Chief Executive Officer ensures that the company maintains a competitive edge within the international CDMO market. Joerg Ahlgrimm drives the expansion of the CGMP facility network, facilitating seamless technology transfer across diverse therapeutic programs. By aligning internal resources with client requirements, the Chief Executive Officer fosters a culture of operational excellence and regulatory compliance. This leadership role involves constant engagement with the Board to secure long-term growth and market stability. Through the optimization of manufacturing processes, the Chief Executive Officer supports the delivery of innovative therapies to patients globally. Ultimately, Ahlgrimm secures the company's position as a premier partner for pharmaceutical development.
David Lowndes - Chief Operating Officer
David Lowndes, the Chief Operating Officer at SK pharmteco, manages the daily execution of complex manufacturing operations across the global network. Focusing on the efficiency of API drug development and production, the Chief Operating Officer implements rigorous quality standards to ensure consistent project delivery. David Lowndes coordinates cross-functional teams to streamline technology transfer, reducing time-to-market for critical therapeutic programs. By overseeing the technical infrastructure and supply chain logistics, the Chief Operating Officer maintains high performance across all CGMP facilities. This role requires constant collaboration with site leaders to resolve operational bottlenecks and enhance production capacity. Through the application of advanced manufacturing methodologies, the Chief Operating Officer drives significant improvements in output and reliability. Ultimately, Lowndes ensures that every client project meets stringent regulatory requirements while maintaining the highest standards of safety and operational excellence.
Kalen Minvielle - President, Small Molecule (North America)
Kalen Minvielle, the President, Small Molecule (North America) at SK pharmteco, directs all regional operations related to small molecule drug development and manufacturing. Overseeing the North American market expansion, the President, Small Molecule (North America) ensures that local facilities meet the specific demands of regional clients. Kalen Minvielle manages the technical teams responsible for API synthesis and regulatory support, driving project success from early development through commercial scale. By fostering strong relationships with regional partners, the President, Small Molecule (North America) secures a robust pipeline of therapeutic programs. This leadership role involves aligning regional manufacturing capabilities with the broader global strategy to maintain consistent quality standards. Through the optimization of local production workflows, the President, Small Molecule (North America) enhances the company's competitive standing in the North American pharmaceutical sector. Ultimately, Minvielle delivers critical manufacturing solutions that accelerate the development of life-saving medications.
Gregory Cloetingh - Chief of Staff
Gregory Cloetingh, the Chief of Staff at SK pharmteco, architects the internal communication frameworks and strategic alignment initiatives that connect executive leadership with operational departments. Managing the flow of information across the organization, the Chief of Staff ensures that corporate objectives remain clear and actionable for all teams. Gregory Cloetingh facilitates high-level project management, enabling the company to execute complex drug development programs with precision. By coordinating efforts between the C-suite and functional leads, the Chief of Staff optimizes decision-making processes and resource allocation. This role involves monitoring key performance indicators to track progress against long-term business goals. Through the implementation of structured governance, the Chief of Staff supports the seamless integration of new technologies and service offerings. Ultimately, Cloetingh drives organizational efficiency, ensuring that the company remains agile and responsive to the evolving needs of the global pharmaceutical industry.
Explore Leadership Teams in Manufacturing
Alkem is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company was established in 1973 and is headquartered in Mumbai, India.
Company Leadership SA
YH
AS
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.
Company Leadership JY
AG
JF
KG
Aurobindo Pharma Limited is a global marketer and manufacturer of generic pharmaceuticals and active pharmaceutical ingredients. The company's product portfolio is spread over major therapeutic/product areas encompassing Antibiotics, AntiRetrovirals, CVS, CNS, Systemic Gastroenterologicals, Anti-Allergies, Anti-Diabetics and other therapeutic areas. Aurobindo is headquartered in Hyderabad, India.
Company Leadership SM
KS

AJ
Sumitomo Pharma seeks to continuously create innovative pharmaceutical products by pursuing R&D activities focused on Psychiatry & Neurology, Oncology, and Regenerative Medicine & Cell Therapy, all the while incorporating cutting-edge technologies. We also seek to contribute to Global Health through our work in the area of Infectious Disease, and furthermore, through our Frontier Business, we are pursuing R&D and commercialization of new healthcare solutions other than pharmaceuticals for addressing social issues which cannot be solved by pharmaceuticals alone.
Company Leadership SK
JH
TS
AS